摘要
目的:探讨百令胶囊治疗慢性马兜铃酸肾病(CAAN)的疗效。方法:治疗组15例CAAN患者,用百令胶囊治疗,治疗效果与用泼尼松治疗组(对照组)12例比较。结果:治疗组治疗后血SCr、Ccr较治疗前无明显变化(P>0.05);对照组治疗后SCr较治疗前明显升高(P<0.05);对照组Ccr低于治疗前(P<0.01)。结论:用百令胶囊能够明显延缓CAAN患者肾功能进行性减退;泼尼松不能够控制CAAN患者肾功能进行性减退。
To investigate the efficacy of corbrin capsule in the treatment of chronic aristolochic acid nephropathy (CAAN). Method: The treated group was treated with corbrin capsule in 15 patients with CAAN. The therapeutic effect was compared with that of the controlled group treated with prednisone. Result: There was a notable increased of SCr and decreased of Ccr after the treatment in the prednisone group (P〈0.05 ) ;but in the treated group ,there was not any notable differences of Scr before and after the treatment ( P〉0.05 ). Conclusion : Corbrin capsule can markedly retard the deterioration of renal function of the patients with CAAN, but prednisone can not.
出处
《中国药师》
CAS
2007年第9期851-853,共3页
China Pharmacist
基金
湖北省科技攻关基金(2005AA301C38)
关键词
慢性马兜铃酸肾病
百令胶囊
泼尼松
Chronic aristolochic acid nephropathy
Corbrin capsule
Prednisone